ArticleBMC cancer2021

Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study.

E Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.